Persistent Mixed Donor Chimerism following Double Umbilical Cord Transplantation in a Patient with T-Cell Prolymphocytic Leukemia

T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive postthymic T-cell neoplasm with an associated survival time of 1 year when left untreated. Current standard of care for T-PLL is with alemtuzumab, followed by allogeneic or autologous stem cell transplant. Little is found in the literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mistry, Ronak H., Hexner, Elizabeth O., Mangan, James K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755299/
https://www.ncbi.nlm.nih.gov/pubmed/31612087
http://dx.doi.org/10.1155/2019/8437805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755299/
https://www.ncbi.nlm.nih.gov/pubmed/31612087
http://dx.doi.org/10.1155/2019/8437805

Ejemplares similares